Officials from Nektar Therapeutics (NASDAQ:NKTR) announced that the company's chief operating officer, Bharatt Chowrira, is leaving his post at the firm effective January 3rd, Bloomberg reports Friday. Chowrira will reportedly rec
From FNNO.com, this is the Financial News Network. I’m Cleo
Stiller-Farrell and this is your Midweek Market Wrap Up. The British
Bankers’ Association, which has the supervisory role of setting the
influential Libor rates, announced that it would be willing to give up
its...
